Research Literature on Food Intolerance and Allergies
General
- 2004 Aljada, Increase in intranuclear factor kB and decrease in inhibitor factor kB in mononuclear cells after a mixed meal. Evidence for a proinflammatory effect.
- 2001 Univ. of York, Report British Allergy Foundation
- 2000 Dixon, Treatment of delayed food allergy based on specific IgG RAST testing
- 1998 Gaby AR, Review food intolerance in chronic disease
Gastro-intestinal problems
- 2010 Bentz et al, Crohn’s disease and IgG
- 2007 Zuo, Alterations of food specific IgG in IBS
- 2006 Drisko, Treating IBS with food elimination diet
- 2005 Shanahan, IgG mediated food intolerance in Irritable Bowel Syndrome
- 2004 Rogler et. al, Food intolerance in Crohn’s disease
- 2004 Atkinson et al., IgG in Irritable Bowel Syndrome
- 2004 Isolauri et. al, IgG in Irritable Bowel Syndrome
- 2004, Lea R., Dietary treatment of IBS (abstract)
Headache, migraine
- 2010 Pascual in CEP IgG and migraine
- 2010 Ertas in CEP Diet restriction in migraine
- 2005 Rees et. al, A prospective audit of food intolerance in migraine patients
Skin diseases
ADHD
Obesity
- 2007 Truschnig et. al, IgG antibodies against food in obese juveniles
- 2005 Dandona, Metabolic syndrome: Obesity, diabetes and inflammation
- 2003 Erlinger et al., Inflammation modifies the effect of a reduced fat low cholesterol diet on lipids
- 2003 Ramos, Is obesity an inflammatory disease?
Miscellaneous
- 2004 Food intolerance in Crohn’s disease
- 2007 Selvin, Paynter, Erlinger, Effect of weight loss on CRP
- 2004 Vance, Ovalbumin specific IgG and development of asthma
- 1998 Wahnschaffe, Serum antibodies to dietary antigens in HIV-1 infection
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002; 115: 18-29
Barbeau WE. Interactions between dietary proteins and the human system: implications for oral tolerance and food-related diseases. Adv Exp Med Biol 1997; 415: 183-193
Bellmann K, Kolb H, Hartmann B, Rothe H, Rowsell P, Rastegar S, Burg-hardt K, Scott FW. Intervention in autoimmune diabetes by targeting the gut immune system. Int J Immu-nopharmacol 1997; 19: 573-577
Bindslev-Jensen C, Skov PS, Madsen F, Poulsen LK. Food allergy and food intolerance - what is the difference? Ann Allergy 1994; 72: 317-320
Borst SE, Bagby GJ. Neutralisation of tumour necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats. Metabolism 2002; 51: 1061-1064
Cavaillon JM. Cytokines in inflammation. C R Seances Biol Fil 1995; 189: 531-544
Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349-356
Groop LC. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes Metab 1999; 1: S1-S7
Groux H, Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today 1999; 20: 442-446
Hanson SJ, Gause W, Natelson B. Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers. Clin Diagn Lab Immunol 2001; 8: 658-662
Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumour necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119
Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995; 154: 6174-6181
Patton JS, Shepard HM, Wilking H, Lewis G, Aggarwal BB, Eessalu TE, Gavin LA, Grunfeld C. Interferons and tumour necrosis factors have similar catabolic effects on 3T3-L1 cells. Proc Natl Acad Sci USA 1986; 83: 8313-8317
Reaven GM. Role of insulin resistance in human disease. Diabetes1988; 37: 1595-1607
Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, Mac-Dermott RP, Raedler A. Enhanced secretion of tumour necrosis factor a, IL-6 and IL- 1b by isolated lamina propria mono-nuclear cells from patients with ulcerative Colitis and Crohn’s disease. Clin Exp Immunol 1993; 94: 174-181
Schafer ML. On the history of the concept neurasthenia and its modern variants chronic-fatigue-syndrome, fibromyalgia and multiple chemical sensitivities. Fortschr Neurol Psychiatry 2002; 70: 570-582
Secundolfo M, de Magistris L, Fiandra R, Caserta L, Bellatta M, Tartaglione MT, Riegler G, Biagi F, Corazza GR, Carratu R. Intestinal permeability in Crohn’s disease patients and their first degree relatives. Dig Liver Dis 2001; 33: 680-685
Targan SR. Biology of inflammation in Crohn’s disease: mechanisms of action of anti-TNF-a therapy. Can J Gastroenterol 2000; 14: S13-16
Tsuji NM, Mizumachi K, Kuriaski J. Interleukin-10-secreting Peyer’s patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 2001; 4: 458-464
Vahasalo P, Petays T, Knip M, Miettinen A, Saukkonen T, Karjalainen J, Savilathi E, Ackerblom HK. Relation between antibodies to islet cell antigens, other auto antigens and cows milk proteins in diabetic children and unaffected siblings at the clinical manifestation of IDDM. The Childhood Diabetes in Finland Study Group. Autoimmunity 1996; 23: 165-174
White KP, Speechley M, Harth M, Ostbye T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. Scand J Rheumatol 2000; 29: 44-51
Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating tumour necrosis factor-a concentrations in a native Canadian population with high rates of type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 272-278